Cargando…

Early acquisition of [(18)F]FDOPA PET/CT imaging in patients with recurrent or residual medullary thyroid cancer is safe—and slightly better!

PURPOSE: The aim of this study was to compare early (15 min) and late (60 min) [(18)F]FDOPA PET/CT acquisition times in the detection of recurrence/residual disease in medullary thyroid cancer (MTC) patients. MATERIALS AND METHODS: Thirty-two dual-phase [(18)F]FDOPA PET scans were retrospectively re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kjærulff, Mette Louise Gram, Dias, André H., Iversen, Peter, Gormsen, Lars Christian, Hjorthaug, Karin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402850/ https://www.ncbi.nlm.nih.gov/pubmed/36002696 http://dx.doi.org/10.1186/s41824-022-00140-7

Ejemplares similares

The Role of (18)F-FDOPA PET/CT in Recurrent Medullary Thyroid Cancer Patients with Elevated Serum Calcitonin Levels
por: Araz, Mine, et al.
Publicado: (2023)

An automatic analysis framework for FDOPA PET neuroimaging
por: Nordio, Giovanna, et al.
Publicado: (2023)

Clinical feasibility and impact of data-driven respiratory motion compensation studied in 200 whole-body (18)F-FDG PET/CT scans
por: Dias, André H., et al.
Publicado: (2022)

Additive Value of Dynamic FDOPA PET/CT for Glioma Grading
por: Girard, Antoine, et al.
Publicado: (2021)

Adrenal tracer uptake by (18)F-FDOPA PET/CT in patients with pheochromocytoma and controls
por: Noordzij, Walter, et al.
Publicado: (2019)

Intrastriatal gradient analyses of 18F-FDOPA PET scans for differentiation of Parkinsonian disorders
por: Stormezand, Gilles N., et al.
Publicado: (2020)

(18)F-FDOPA PET/CT accurately identifies MEN1-associated pheochromocytoma
por: Tepede, Aisha A, et al.
Publicado: (2020)

Comparison of 6-[(18)F]FDOPA PET with Nigrosome 1 detection in patients with parkinsonism
por: Michler, Enrico, et al.
Publicado: (2021)

Pharmacokinetic Modeling of (18)F-FDOPA PET in the Human Brain for Early Parkinson’s Disease
por: Buratachwatanasiri, Wirunpatch, et al.
Publicado: (2021)

Effects of Carbidopa Premedication on (18)F-FDOPA PET Imaging of Glioma: A Multiparametric Analysis
por: Bros, Marie, et al.
Publicado: (2021)

Implementing the Point Spread Function Deconvolution for Better Molecular Characterization of Newly Diagnosed Gliomas: A Dynamic (18)F-FDOPA PET Radiomics Study
por: Ahrari, Shamimeh, et al.
Publicado: (2022)

Usefulness of (18)F-FDOPA PET for the management of primary brain tumors: a systematic review of the literature
por: Somme, François, et al.
Publicado: (2020)

Dynamic (18)F-FDopa PET Imaging for Newly Diagnosed Gliomas: Is a Semiquantitative Model Sufficient?
por: Zaragori, Timothée, et al.
Publicado: (2021)

A potential biomarker for treatment stratification in psychosis: evaluation of an [(18)F] FDOPA PET imaging approach
por: Veronese, Mattia, et al.
Publicado: (2020)

Accurate detection of intracranial extension of jugulotympanic paraganglioma by [(18)F]FDOPA-PET/CT comparing to MRI
por: Araghi, Zahra Jamshidi, et al.
Publicado: (2021)

Development and validation of a radiomic model for the diagnosis of dopaminergic denervation on [18F]FDOPA PET/CT
por: Comte, Victor, et al.
Publicado: (2022)

Diagnostic and grading accuracy of (18)F-FDOPA PET and PET/CT in patients with gliomas: a systematic review and meta-analysis
por: Xiao, Jiarui, et al.
Publicado: (2019)

Use of [(18)F]FDOPA-PET for in vivo evaluation of dopaminergic dysfunction in unilaterally 6-OHDA-lesioned rats
por: Kyono, Kiyoshi, et al.
Publicado: (2011)

Impact of non-uniform attenuation correction in a dynamic [(18)F]-FDOPA brain PET/MRI study
por: Cabello, Jorge, et al.
Publicado: (2019)

Automated Data Quality Control in FDOPA brain PET Imaging using Deep Learning
por: Pontoriero, Antonella D., et al.
Publicado: (2021)

(18)F-FDOPA PET/CT Combined with MRI for Gross Tumor Volume Delineation in Patients with Skull Base Paraganglioma
por: Helali, Mehdi, et al.
Publicado: (2019)

18F-FDOPA PET/CT SUV-Derived Indices and Volumetric Parameters Correlation in Patients with Primary Brain Tumors
por: Chiaravalloti, Agostino, et al.
Publicado: (2021)

Intravenous and oral whole body ketone dosimetry, biodistribution, metabolite correction and kinetics studied by (R)-[1-(11)C]β-hydroxybutyrate ([(11)C]OHB) PET in healthy humans
por: Luong, Thien Vinh, et al.
Publicado: (2023)

Clinical impact of dual-tracer FDOPA and FDG PET/CT for the evaluation of patients with parkinsonian syndromes
por: Emsen, Berivan, et al.
Publicado: (2020)

SAT-310 (18)F-FDOPA PET/CT Accurately Identifies Pheochromocytoma in 70-Year-Old Male with MEN1
por: Tepede, Aisha, et al.
Publicado: (2019)

The impact of 18F-FDOPA-PET/MRI image fusion in detecting liver metastasis in patients with neuroendocrine tumors of the gastrointestinal tract
por: Barachini, O., et al.
Publicado: (2020)

A comparative study of standardized quantitative and visual assessment for predicting tumor volume and outcome in newly diagnosed diffuse large B-cell lymphoma staged with 18F-FDG PET/CT
por: Gormsen, Lars C., et al.
Publicado: (2019)

MLTI-18. PRECISION IMAGING OF METASTATIC AND PRIMARY BRAIN TUMORS AFTER RADIATION WITH (18)F-FDOPA PET-MRI IS FEASIBLE AND COST EFFECT
por: Aboian, Mariam, et al.
Publicado: (2019)

The effects of molar activity on [(18)F]FDOPA uptake in patients with neuroendocrine tumors
por: Stormezand, Gilles N., et al.
Publicado: (2021)

Striatal dopamine synthesis capacity in autism spectrum disorder and its relation with social defeat: an [(18)F]-FDOPA PET/CT study
por: Schalbroeck, Rik, et al.
Publicado: (2021)

Correlation between (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in patients with Parkinson’s disease: a pilot study
por: Arena, Julieta E., et al.
Publicado: (2021)

Evaluation of Intraperitoneal [(18)F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis Capacity
por: Halff, Els F., et al.
Publicado: (2022)

Nucleophilic Synthesis of 6-l-[(18)F]FDOPA. Is Copper-Mediated Radiofluorination the Answer?
por: Krasikova, Raisa N.
Publicado: (2020)

Comparative evaluation of 18F-FDOPA, 13N-AMMONIA, 18F-FDG PET/CT and MRI in primary brain tumors - A pilot study
por: Jora, Charu, et al.
Publicado: (2011)

(18)F-Fluorine-18-l-dihydroxyphenylalanine ((18)F-DOPA) positive isolated peritoneal carcinomatosis from a MENII-related medullary thyroid carcinoma. About an atypical metastatic site and utility of (18)F-FDOPA
por: Aziz, Anne-Laure, et al.
Publicado: (2015)

Optimization of time frame binning for FDOPA uptake quantification in glioma
por: Girard, Antoine, et al.
Publicado: (2020)

Cerebral [(18)F]-FDOPA Uptake in Autism Spectrum Disorder and Its Association with Autistic Traits
por: Schalbroeck, Rik, et al.
Publicado: (2021)

Enzyme inhibition of dopamine metabolism alters 6-[(18)F]FDOPA uptake in orthotopic pancreatic adenocarcinoma
por: Tuomela, Johanna, et al.
Publicado: (2013)

[18F] FDOPA standardized uptake values of brain tumors are not exclusively dependent on LAT1 expression
por: Dadone-Montaudié, Bérengère, et al.
Publicado: (2017)

SUN-116 The Role of (68)Gallium DOTATATE PET/CT Versus (18)F-FDOPA PET/CT in the Imaging of Neuroendocrine Neoplasms in Patients with Multiple Endocrine Neoplasia Type 1 (MEN1)
por: Tepede, Aisha, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_elev46bv41a5paf2uh3nt269l0